KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Asset Writedowns and Impairment: 2020-2025

Historic Asset Writedowns and Impairment for Exact Sciences (EXAS) over the last 2 years, with Sep 2025 value amounting to $543,000.

  • Exact Sciences' Asset Writedowns and Impairment fell 97.10% to $543,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $863.7 million, marking a year-over-year increase of 2611.81%. This contributed to the annual value of $869.5 million for FY2024, which is 139909.66% up from last year.
  • As of Q3 2025, Exact Sciences' Asset Writedowns and Impairment stood at $543,000, which was down 91.31% from $6.3 million recorded in Q1 2025.
  • Exact Sciences' 5-year Asset Writedowns and Impairment high stood at $838.2 million for Q4 2024, and its period low was $69,000 during Q1 2023.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $5.3 million (2024), whereas its average is $109.6 million.
  • As far as peak fluctuations go, Exact Sciences' Asset Writedowns and Impairment soared by 6,343.48% in 2024, and later crashed by 97.10% in 2025.
  • Quarterly analysis of 5 years shows Exact Sciences' Asset Writedowns and Impairment stood at $20.2 million in 2021, then slumped by 70.58% to $3.4 million in 2022, then slumped by 91.62% to $552,000 in 2023, then surged by 1,376.81% to $838.2 million in 2024, then crashed by 97.10% to $543,000 in 2025.
  • Its Asset Writedowns and Impairment stands at $543,000 for Q3 2025, versus $6.3 million for Q1 2025 and $838.2 million for Q4 2024.